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a b s t r a c t
Objective: Compare the level of vitamin D with the bone mineral density (BMD) in 
postmenopausal women, with or without fractures. Methods: 250 women with mean age of 
71.1 were evaluated. The serum levels of vitamin D considered sufficient were ≥ 30 ng/mL, 
insufficient between 20 and 30 ng/mL and deficient < 20 ng/mL. The bone mineral density 
was measured and considered osteopenia when T value total of lumbar spine or hip was 
between -1 and -2.5 and osteoporosis < 2.5. The patients with fractures accounted for 25.2%. 
Results: There was no significant difference in the vitamin D (ng/mL) levels among the age 
groups (p = 0.25), the levels of fractures (p = 0.79) and the levels of BMD (p = 0.76). Conclusion: 
82% of the patients presented deficient and insufficient blood levels of vitamin D. Ours results 
showed any significant correlation between vitamin D levels and bone mineral density after 
adjusting for age.
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora 
Ltda.   
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Introduction
The loss of bone density in postmenopausal women has 
been linked to a subclinical deficiency in vitamin D, which 
is considered to be a risk factor for fractures due to the 
susceptibility of this population to falls and inappropriate 
neuromuscular responses.1-4 Vitamin D insufficiency can 
result from nutritional deficiency and/or low sun exposure 
in confined elderly patients and inpatients with chronic 
diseases.5-8
Studies have shown that female patients who ingest high 
levels of calcium exhibit high bone mineral density when 
compared to female patients with low calcium ingestion. 
Vitamin D and calcium supplements aid in the prevention of 
bone loss by reducing bone renewal and the number of non-
vertebral fractures.9 
Supplemental vitamin D and calcium (500-1,200 mg/d) 
seems to reduce the risk of secondary hyperparathyroidism due 
to vitamin D insufficiency.10 Vitamin D is absorbed through 
two mechanisms: the activation of the 7-dehydrocholesterol 
pathway in the skin by sunlight and the intestinal absorption of 
the vitamin D in food. The appropriate serum level of vitamin 
D is approximately 30 to 55 ng/mL. Values below 20 ng/mL are 
considered to be deficient and levels in the 20 to 30 ng/mL 
range are considered inappropriate.11,12
The objective of this paper was to compare the vitamin D 
levels and BMD of postmenopausal women with or without 
fractures. 
Materials and Methods
Two hundred fifty women with a mean age of 71.1 years old (45 
to 98) were evaluated between January 2010 and December 2011. 
The included patients were postmenopausal women who had 
reached menopause two years before and had received a bone 
densitometry scan at least six months prior to the initial visit. 
The women underwent analysis to determine their vitamin 
D level and were not using a corticosteroid. The serum 
vitamin D levels were measured by electrochemiluminescence; 
values ≥ 30 ng/mL were considered normal, values between 
20 and 30 ng/mL were considered insufficient and values 
< 20 ng/mL were considered deficient. The patients’ BMD in 
the region of the hips and the lumbar spine was measured 
with GER’s Lunar Prodigy Advance Densitometer with fan bean 
technology. The hip densitometry measurement included the 
trochanter, the femur neck and the intertrochanteric region. 
The lumbar spine densitometry measurement included the 
lumbar vertebrae L1- L4. The included software calculated 
the T and Z values relative to North-American reference values. 
Osteopenia was defined as a T-score between -1 and -2.5 at 
the lumbar spine or hips and osteoporosis was defined as a 
T-score < -2.5.
The sample characterization was aimed at developing 
a general profile of the 250 female patients studied. Table 1 
shows the mean, the standard deviation (SD), the median, 
Variable Mean SD Median Minimum Maximum
Age (years) 71.1 10.3 71 45 98
Vitamin D 2.8 10.5 21.8 5.7 80.9
Spine BMD -1.4 1.4 -1.5 -4.6 3.7
Femur BMD * -1.3 1.2 -1.3 -5.4 2
SD: Standard Deviation. * corresponds to the lower BMD value in 
the bilateral cases. Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 1 - General Description of Numeric Variables.
and the minimum and maximum numeric variables. Table 2 
provides the frequency (n) and the percentage (%) of the 
categorical variables.
Statistical Methodology
The tables summarize the data observed, which were expressed 
as the frequency (n) and percentage (%) for categorical 
(qualitative) data and as the mean, standard deviation, median 
and the minimum and maximum for numeric data. 
The statistical analysis consisted of the following methods:
- the numeric variables for two subgroups were compared 
using the Student’s t test for independent samples or the 
Mann-Whitney test; comparisons among three subgroups 
were analyzed using a one-way ANOVA or the Kruskal-
Wallis Anova test (non-parametric). Tukey’s or Dunn’s 
multiple comparison tests (non-parametric) were applied 
to identify which groups were significantly different from 
each other at the level of 5%, and
- the categorical variables for the subgroups were compared 
using the F2 test. 
Variable Category n %
Age (years)
45 to 49 4 1.6
50 to 59 28 11.2
60 to 69 76 30.4
70 to 79 89 35.6
80 to 89 45 18.0
90 to 99 8 3.2
Fracture
yes 63 25.2
no 187 74.8
Vitamin D 
(classification)
≤ 20 94 37.6
21 to 29 111 44.4
≥ 30 45 18.0
BMD 
(classification)
normal 58 23.2
osteopenia 114 45.6
78 31.2
Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 2 - General Description of Categorical Variables.
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Non-parametric tests were applied because some variables 
did not present a normal distribution (Gaussian); due to data 
dispersion, the null hypothesis was rejected according to the 
Kolmogorov-Smirnov test. Significance was defined at the level 
of 5%. SAS 6.11 (SAS Institute, Inc., Cary, North Carolina, USA) 
software was used to complete the statistical analysis.
Results
The first objective was to verify if there were significant 
differences between fracture status (present or not), vitamin 
D level (deficient, insufficient and sufficient) and BMD (normal, 
osteopenia and osteoporosis) with relation to the mean age of 
the patients (in years). 
Table 3 summarizes the mean ± standard deviation (SD) of 
the patients’ age based on the fracture status, vitamin D level 
and BMD and the corresponding p values calculated by the 
appropriate statistical test.  
The statistical analysis utilized the Student’s t test for 
independent samples to compare two categories (levels) or the 
one-way Anova to compare three categories. Tukey’s multiple 
comparison test was used to identify which categories were 
significantly different from each other at a level of 5%.
Subgroup Category n Mean ± SD p valuea
Fracture
yes 63 75.3 ± 11.5
0.0002
no 187 69.7 ± 9.5
BMD 
(classification)
normal 58 68.4 ± 10.4
0.0001osteopenia 114 69.6 ± 9.7
osteoporosis 78 75.3 ± 10.0
Vitamin D 
(classification)
deficiency 94 72.6 ± 10.5
0.13insufficient 111 69.7 ± 9.6
sufficient 45 71.5 ± 11.3
aStudent’s t test for independent samples or one-way Anova.
Table 3 - Mean patient age (years) for each of the fracture, 
vitamin D3 and BMD categories.
Variable Category n Median Minimum Maximum p valuea
Age (years)
45 to 59 32 21.7 14.1 56.9
0.25
60 to 69 76 22.2 9.7 64.7
70 to 79 89 20.8 9.0 80.9
80 to 99 53 22.6 5.7 72.0
Fracture
yes 63 22.1 5.7 72.0
0.79
no 187 21.6 6.2 80.9
BMD 
(classification)
normal 58 21.2 9.3 64.7
0.76osteopenia 114 21.9 9.0 52.4
osteoporosis 78 22.2 5.7 80.9
aMann-Whitney test or Kruskal-Wallis Anova. Source: Hospital Santa Teresa. Petrópolis. RJ.
Table 4 - Vitamin D level (ng/mL) for each age group, fracture status and BMD category.
The mean age of the subgroup of patients with fractures was 
significantly higher than the mean age of the subgroup 
without fractures (p = 0.0002). The mean ages of the 
patients with differing BMD levels were also significantly 
different (p = 0.0001). The mean age of the subgroup of patients 
with osteoporosis was significantly higher than the mean ages 
of the subgroups with normal BMD and osteopenia.
There was no significant difference in the mean age of 
patients with different vitamin D levels (p = 0.13).
The second objective was to verify if there was significant 
difference in the vitamin D levels (in ng/mL) of the patients 
with different ages, fracture statuses and BMD levels. Table 4 
summarizes the median, the minimum and maximum vitamin 
D levels (ng/mL) for each age group (45 to 59, 60 to 69, 70 to 
79 and 80 to 99 years old), fracture status (present or not) 
and BMD level (normal, osteopenia and osteoporosis) and 
the corresponding p value of the statistical test used for the 
comparison.
The statistical analysis utilized the Mann-Whitney test 
to compare two categories (levels) or the Kruskal-Wallis Anova to 
compare three categories. Dunn’s multiple comparison test was 
used to identify which categories were significantly different 
from each other at a level of 5%. 
There were no significant differences in the vitamin D levels 
(ng/mL) among the age groups (p = 0.25), the fracture status 
(p = 0.79) or the BMD levels (p = 0.76) (Fig. 1).
The third objective sought to identify whether there was 
significant association among the following variables: age 
group, fracture status, vitamin D level and BMD. Tables 5, 6, 
7 and 8 provide the frequency (n) and the percentage (%) of 
the contingency tables for the four variables studied and the 
corresponding p value of the F2 test. The analyses were repeated 
and are only presented if the results differed. 
Age group was significantly associated with the presence of 
fracture (p < 0.0001) and osteoporosis (p = 0.006).
The presence of fracture was significantly associated with 
age group (p < 0.0001) and osteoporosis (p = 0.011).
Vitamin D levels were not significantly associated with 
age group (p = 0.22), fracture (p = 0.82) or BMD (p = 0.77) 
(Fig. 2). 
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Variable Category 
45 to 59 years old 60 to 69 years old 70 to 79 years old 80 to 99 years old
p valuean % n % n % n %
Fracture
yes 7 21.9 12 15.8 19 21.4 25 47.2
< 0.0001
no 25 78.1 64 84.2 70 78.7 28 52.8
Vitamin D 
(classification)
deficiency 10 31.3 26 34.2 39 43.8 19 35.9
0.22insufficient 16 50.0 36 47.4 40 44.9 19 35.9
sufficient 6 18.8 14 18.4 10 11.2 15 28.3
DMO 
(classification)
normal 12 37.5 19 25.0 19 21.4 8 15.1
0.006osteopenia 15 46.9 40 52.6 41 46.1 18 34.0
osteoporosis 5 15.6 17 22.4 29 32.6 27 50.9
a F2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 5 – Association between each of the variables and age.
Variable Category 
With Fracture Without Fracture
p valuean % n %
Age (years)
45 to 59 7 11.1 25 13.4
< 0.0001
60 to 69 12 19.1 64 34.2
70 to 79 19 30.2 70 37.4
80 to 99 25 39.7 28 15.0
Vitamin D 
(classification)
deficiency 23 36.5 71 38.0
0.82insufficient 27 42.9 84 44.9
sufficient 13 20.6 32 17.1
BMD 
(classification)
normal 7 11.1 51 27.3
0.011osteopenia 29 46.0 85 45.5
osteoporosis 27 42.9 51 27.3
a F2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 6 - Association between each of the variables and fracture status.
Fig. 1- Relationship between vitamin D level and age. Fig. 2 - Vitamin D levels for each BMD category.
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Variable Category 
Normal Osteopenia Osteoporosis
p valuean % n % n %
Age 
(years)
45 to 59 12 20.7 15 13.2 5 6.4
0.006
60 to 69 19 32.8 40 35.1 17 21.8
70 to 79 19 32.8 41 36.0 29 37.2
80 to 99 8 13.8 18 15.8 27 34.6
Fracture
yes 7 12.1 29 25.4 27 34.6
0.011
no 51 87.9 85 74.6 51 65.4
BMD 
(classification)
deficiency 25 43.1 39 34.2 30 38.5
0.77insufficient 22 37.9 55 48.3 34 43.6
sufficient 11 19.0 20 17.5 14 18.0
a F2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 8 - Association between each of the variables and BMD.
Variable Category 
Deficient Insufficient Sufficient
p valuean % n % n %
Age 
(years)
45 to 59 10 10.6 16 14.4 6 13.3
0.22
60 to 69 26 27.7 36 32.4 14 31.1
70 to 79 39 41.5 40 36.0 10 22.2
80 to 99 19 20.2 19 17.1 15 33.3
Fracture
yes 23 24.5 27 24.3 13 28.9
0.82
no 71 75.5 84 75.7 32 71.1
BMD 
(classification)
normal 25 26.6 22 19.8 11 24.4
0.77osteopenia 39 41.5 55 49.6 20 44.4
osteoporosis 30 31.9 34 30.6 14 31.1
a F2 test. Source: Hospital Santa Teresa, Petrópolis, RJ.
Table 7 - Association between each of the variables and vitamin D level.
Osteoporosis was significantly associated with age group 
(p = 0.006) and the presence of fracture (p = 0.011).   
Discussion
Vitamin D is extremely important for calcium absorption. 
When serum vitamin D levels decrease, the parathyroid 
hormone level increases and calcium absorption decreases. 
Vitamin D is absorbed through two mechanisms: the 
activation of the 7-dehydrocholesterol pathway in 
the skin by sunlight and intestinal absorption from the 
diet. Although vitamin D deficiency is relatively rare in 
the healthy young population, this deficiency is common 
in the elderly population, especially among inpatients or 
individuals who live in countries where sunlight is limited.12 
It is worth mentioning that vitamin D deficiency is not only 
limited to the bones or muscles. Recent epidemiological 
data on vitamin D deficiency have shown an association 
with arthritis, as well as with non-skeletal diseases such as 
prostate, colon and breast cancer; diabetes mellitus types 
1 and 2; multiple sclerosis; hypertension; cardiovascular 
disease and schizophrenia.11 This study analyzed the 
relationship between vitamin D levels and age but did 
not find any significant difference in the vitamin D levels 
of different age groups. However, more than 70% of the 
patients in each of the age groups exhibited deficient or 
insufficient levels of vitamin D. Therefore, it is advisable to 
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measure serum vitamin D levels at all ages, as deficient and 
insufficient levels may accelerate bone deterioration and 
cause osteoporosis. 
The link between vitamin D and bone mineral density is 
still being discussed. An evaluation of the vitamin D level 
in patients with osteoporosis is essential for two reasons. 
First, vitamin D deficiency in patients with osteoporosis 
causes demineralization that may reduce bone mass.13,14 
Second, it is important to achieve suitable levels of vitamin 
D in patients with osteoporosis to maximize the response 
to antiresorptive therapy, facilitate changes in bone mineral 
density and efficiently manage fractures.15 Several studies 
have suggested that low serum vitamin D levels are 
associated with low bone mineral density.16-18 Bischoff-
Ferrari et al.19 found a positive relationship between vitamin 
D levels and bone mineral density in young Caucasians and 
elderly men. However, other studies have not supported 
this association.20-22 The heterogeneity of the results can 
be partially explained by ethnic differences in the patient 
populations and differing age groups, as well as by the fact 
that the studies focused on different regions of the human 
body. Garnero et al.23 and Allali et al.24 were unable to show 
a significant correlation between vitamin D levels and bone 
mineral density. Rassouli et al.25 found a correlation with 
the bone mineral density of the spine, but not the hips. 
Sadat-Ali et al.26 found that most patients with vitamin D 
insufficiency exhibit low bone mass and that all patients 
with vitamin D deficiency have bone mineral densities 
varying between osteopenia and osteoporosis. This group 
also found a correlation between vitamin D levels and 
bone mineral density in most patients, particularly those 
groups exhibiting insufficiency and deficiency. The authors 
emphasized the importance of measuring vitamin D levels 
in patients with low bone mass instead of relying only 
on bone densitometry. Bandeira et al.27 found vitamin 
D deficiencies in healthy postmenopausal women of all 
ages during routine doctor’s appointments. The authors 
concluded that those individuals exhibiting vitamin D 
levels lower than 25 ng/mL were elderly patients who had 
reached menopause a long time ago. These patients also 
exhibited low bone mineral density on the femur neck and 
high levels of parathyroid hormone. This study indicated 
that 91.1% of the patients with osteopenia exhibited 
deficient and insufficient serum vitamin D levels (41.5% 
and 49.6%, respectively) and that 62.5% of the patients 
with osteoporosis exhibited deficient and insufficient 
serum vitamin D levels (31.9% and 30.6%, respectively). 
However, 46.4% of the normal patients exhibited deficient 
and insufficient serum vitamin D levels (26.6% and 19.8%, 
respectively). It is worth mentioning that all of the women 
in this study were Caucasians from the same region 
(latitude and altitude).
Recent evidence has indicated that sun exposure does not 
guarantee a healthy vitamin D level. Brinkley et al.28 evaluated 
93 young adults from Hawaii who experienced sun exposure 
without protection for more than 20 hours per week, finding 
that 51% of the individuals studied exhibited inappropriate 
levels of vitamin D (< 30 ng/mL). Because Brazil is a tropical 
country, the population is expected to have adequate vitamin 
D levels. However, two studies conducted in elderly patients in 
the southeastern region of the country (latitude 20-30°S) found 
a high prevalence of vitamin D deficiency.29-32
Vitamin D deficiency is present in all regions, but is higher 
in southern Asia and the Middle East.33 In our study, we 
analyzed well nourished Caucasian women who had reached 
menopause two years before commencement of the study 
who lived in the same region (22° 30’ 16.70”S latitude, 43° 
10’ 56.38”W longitude in a region with a highland tropical 
climate) in a city lying 838 meters above the sea level. The 
study results indicated that 37.6% of the patients exhibited 
deficient serum vitamin D levels.  Eighty-two percent of the 
patients had insufficient and deficient serum vitamin D levels. 
In the United States of America, the results of the National 
Health and Nutrition Examination Survey registered deficient 
vitamin D values in 30% of the patients studied, with 70% 
of those studied falling into the insufficient and deficient 
categories.34 Patton et al.35 reported that, regardless of the 
cut-off value, vitamin D levels were relatively low in women 
when compared with men and low in the Hispanic and Afro-
descendant population when compared with the Caucasian 
population.    
Hypovitaminosis D has been identified in patients 
with orthopedic pathologies, especially fractures. Several 
authors have reported vitamin D insufficiency after 
orthopedic surgeries, with prevalence varying from 15 to 
24%.36,37 Approximately 80% of patients in an Australian 
hip fracture study presented with insufficient vitamin 
D levels, with more than 30% of these patients also 
exhibiting secondary hyperparathyroidism.38 Despite the 
fact that the results of this study were not statistically 
significant, 42.9% of the patients with fractures exhibited 
vitamin D insufficiency. 
It is worth mentioning that this research did not investigate 
parathyroid hormone levels, which could confound the bone 
density evaluation (secondary hyperparathyroidism) and lead 
to osteoporosis in the presence of vitamin D deficiency. 
Conclusion
Although this study was carried out in a region with a highland 
tropical climate, 82% of the patients exhibited deficient or 
insufficient serum vitamin D levels. Our results did not show 
a significant correlation between vitamin D levels and bone 
mineral density according to age.   
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